|
Insider Trading: Caliper Life Sciences Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Caliper Life Sciences Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Caliper Life Sciences Inc since year 2005. Table 2 shows the detailed insider transactions of Caliper Life Sciences Inc since 2005.
The reporting company's ticker symbol is CALP.
The reporting company's CIK number is 1014672.
The total value of stock buying since 2005 is $587,355.
The total value of stock sales is $1,483,051.
The total value of stock exercises is $484,958.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Caliper Life Sciences Inc (CALP) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Figure 2. Average prices of insider buys, sales, and option exercises at Caliper Life Sciences Inc (CALP) in the past 24 months. See table 2 for insider transaction details.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Caliper Life Sciences Inc (CALP).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-08 | 0 | 0 | 0 | 0 | 10,000 | 30,500 |
| 2008-07 | 0 | 0 | 0 | 0 | 20,000 | 78,600 |
| 2008-06 | 0 | 0 | 1,500 | 5,253 | 26,202 | 85,930 |
| 2008-05 | 0 | 0 | 50,000 | 177,033 | 50,000 | 48,357 |
| 2008-04 | 0 | 0 | 25,000 | 91,302 | 33,750 | 60,491 |
| 2008-03 | 0 | 0 | 4,700 | 19,337 | 9,000 | 34,020 |
| 2007-12 | 0 | 0 | 35,849 | 201,290 | 0 | 0 |
| 2007-11 | 0 | 0 | 27,151 | 152,910 | 0 | 0 |
| 2007-10 | 0 | 0 | 27,000 | 159,317 | 0 | 0 |
| 2007-09 | 0 | 0 | 6,751 | 37,436 | 0 | 0 |
| 2007-08 | 0 | 0 | 6,000 | 34,380 | 0 | 0 |
| 2007-07 | 0 | 0 | 0 | 0 | 20,000 | 97,200 |
| 2007-03 | 0 | 0 | 0 | 0 | 9,000 | 49,860 |
| 2006-11 | 0 | 0 | 50,000 | 276,293 | 0 | 0 |
| 2006-03 | 87,665 | 587,355 | 50,000 | 328,500 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Caliper Life Sciences Inc (CALP)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-08-18 | Hrusovsky E Kevin (President & CEO) | Option Exercise | 10,000 | 3.05 | 30,500 |
| 2008-07-30 | Hrusovsky E Kevin (President & CEO) | Option Exercise | 20,000 | 3.93 | 78,600 |
| 2008-06-06 | Comstock Allan L (Director) | Option Exercise | 4,117 | 3.42 | 14,080 |
| 2008-06-06 | Billet Van (Director) | Option Exercise | 4,117 | 3.42 | 14,080 |
| 2008-06-06 | Milligan David V (Director) | Option Exercise | 4,117 | 3.42 | 14,080 |
| 2008-06-06 | Carter David Warren (Director) | Option Exercise | 4,117 | 3.42 | 14,080 |
| 2008-06-06 | Tunstall Kathryn (Director) | Option Exercise | 4,117 | 3.42 | 14,080 |
| 2008-06-06 | Bishop Robert C (Director) | Option Exercise | 4,117 | 3.42 | 14,080 |
| 2008-06-03 | Kisner Daniel L (Other) | Sale | 1,200 | 3.50 | 4,200 |
| 2008-06-03 | Kisner Daniel L (Other) | Option Exercise | 1,200 | .97 | 1,160 |
| 2008-06-02 | Kisner Daniel L (Director) | Sale | 300 | 3.51 | 1,053 |
| 2008-06-02 | Kisner Daniel L (Director) | Option Exercise | 300 | .97 | 290 |
| 2008-05-30 | Kisner Daniel L (Director) | Sale | 8,412 | 3.50 | 29,442 |
| 2008-05-30 | Kisner Daniel L (Director) | Option Exercise | 8,412 | .97 | 8,136 |
| 2008-05-19 | Kisner Daniel L (Director) | Sale | 13,510 | 3.51 | 47,359 |
| 2008-05-19 | Kisner Daniel L (Director) | Option Exercise | 13,510 | .97 | 13,066 |
| 2008-05-16 | Kisner Daniel L (Director) | Sale | 3,078 | 3.50 | 10,788 |
| 2008-05-16 | Kisner Daniel L (Director) | Option Exercise | 3,078 | .97 | 2,977 |
| 2008-05-13 | Kisner Daniel L (Director) | Sale | 617 | 3.50 | 2,159 |
| 2008-05-13 | Kisner Daniel L (Director) | Option Exercise | 617 | .97 | 596 |
| 2008-05-06 | Kisner Daniel L (Director) | Sale | 2,400 | 3.54 | 8,488 |
| 2008-05-06 | Kisner Daniel L (Director) | Option Exercise | 2,400 | .97 | 2,321 |
| 2008-05-05 | Kisner Daniel L (Director) | Sale | 6,583 | 3.53 | 23,216 |
| 2008-05-05 | Kisner Daniel L (Director) | Option Exercise | 6,583 | .97 | 6,367 |
| 2008-05-02 | Kisner Daniel L (Director) | Sale | 9,600 | 3.60 | 34,568 |
| 2008-05-02 | Kisner Daniel L (Director) | Option Exercise | 9,600 | .97 | 9,285 |
| 2008-05-01 | Kisner Daniel L (Director) | Sale | 5,800 | 3.62 | 21,013 |
| 2008-05-01 | Kisner Daniel L (Director) | Option Exercise | 5,800 | .97 | 5,609 |
| 2008-04-16 | Kisner Daniel L (Director) | Sale | 5,300 | 3.61 | 19,142 |
| 2008-04-16 | Kisner Daniel L (Director) | Option Exercise | 5,300 | .97 | 5,126 |
| 2008-04-15 | Kisner Daniel L (Director) | Sale | 6,000 | 3.66 | 21,938 |
| 2008-04-15 | Kisner Daniel L (Director) | Option Exercise | 6,000 | .97 | 5,803 |
| 2008-04-14 | Kisner Daniel L (Director) | Sale | 13,700 | 3.67 | 50,222 |
| 2008-04-14 | Kisner Daniel L (Director) | Option Exercise | 13,700 | .97 | 13,250 |
| 2008-04-04 | Hrusovsky E Kevin (President & CEO) | Option Exercise | 8,750 | 4.15 | 36,312 |
| 2008-03-29 | Hrusovsky E Kevin (President & CEO) | Option Exercise | 9,000 | 3.78 | 34,020 |
| 2008-03-14 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 4,700 | 4.11 | 19,337 |
| 2007-12-20 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 1,720 | 5.50 | 9,460 |
| 2007-12-19 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 780 | 5.53 | 4,310 |
| 2007-12-17 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 6,500 | 5.63 | 36,625 |
| 2007-12-10 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 9,000 | 5.81 | 52,280 |
| 2007-12-03 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 17,849 | 5.52 | 98,615 |
| 2007-11-30 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 18,151 | 5.59 | 101,418 |
| 2007-11-05 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 9,000 | 5.72 | 51,492 |
| 2007-10-29 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 9,000 | 5.88 | 52,944 |
| 2007-10-22 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 9,000 | 5.80 | 52,238 |
| 2007-10-15 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 9,000 | 6.02 | 54,135 |
| 2007-09-14 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 2,000 | 5.42 | 10,840 |
| 2007-09-10 | Mcaree Peter F (Vice President of Finance) | Sale | 2,801 | 5.55 | 15,552 |
| 2007-09-07 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 1,680 | 5.65 | 9,492 |
| 2007-09-06 | Mcaree Peter F (Vice President of Finance) | Sale | 270 | 5.75 | 1,552 |
| 2007-08-23 | Creager Stephen E (VP and General Counsel) | Sale | 3,000 | 5.77 | 17,310 |
| 2007-08-22 | Creager Stephen E (VP and General Counsel) | Sale | 3,000 | 5.69 | 17,070 |
| 2007-07-30 | Hrusovsky E Kevin (President & CEO) | Option Exercise | 20,000 | 4.86 | 97,200 |
| 2007-03-29 | Hrusovsky E Kevin (President & CEO) | Option Exercise | 9,000 | 5.54 | 49,860 |
| 2006-11-30 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 8,882 | 5.53 | 49,117 |
| 2006-11-28 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 41,118 | 5.52 | 227,176 |
| 2006-03-14 | Manyak David M (Exec VP, Drug Discovery Svcs) | Sale | 50,000 | 6.57 | 328,500 |
| 2006-03-08 | Platinum Asset Management Ltd (10% Owner) | Purchase | 87,665 | 6.70 | 587,355 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Caliper Life Sciences Inc (symbol CALP,
CIK number 1014672) see
the Securities and Exchange Commission (SEC) website.
|
|
